Universe Pharmaceuticals (UPC) Equity Average: 2021-2024
- Universe Pharmaceuticals' Equity Average fell 0.42% to $37.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $37.4 million, marking a year-over-year decrease of 0.42%. This contributed to the annual value of $36.7 million for FY2024, which is 16.07% up from last year.
- Universe Pharmaceuticals' Equity Average amounted to $37.4 million in Q3 2024, which was up 30.63% from $28.6 million recorded in Q1 2024.
- Over the past 5 years, Universe Pharmaceuticals' Equity Average peaked at $54.1 million during Q1 2022, and registered a low of $28.6 million during Q1 2024.
- For the 3-year period, Universe Pharmaceuticals' Equity Average averaged around $41.2 million, with its median value being $39.4 million (2023).
- Its Equity Average has fluctuated over the past 5 years, first soared by 42.32% in 2022, then tumbled by 30.57% in 2024.
- Over the past 4 years, Universe Pharmaceuticals' Equity Average (Quarterly) stood at $33.9 million in 2021, then soared by 42.32% to $48.2 million in 2022, then dropped by 22.17% to $37.5 million in 2023, then declined by 0.42% to $37.4 million in 2024.
- Its Equity Average was $37.4 million in Q3 2024, compared to $28.6 million in Q1 2024 and $37.5 million in Q3 2023.
